We invite you to participate in the III Nutraceutical Days organized by the Nutrigenomics Research Group, as part of the activities of the Uriach Chair of Nutraceuticals at the Rovira i Virgili University.

The conference will take place at the Tarraconense Center El Seminari in Tarragona.

During these two days, we will explore the latest advances in the field of nutraceuticals, with informative sessions and presentations by experts. It is a unique opportunity to first hand learn about the latest research in nutraceuticals.

REGISTER FOR FREE until the next March 4, 2024.


Read more
Researchers from the Nutrition and Metabolic Health (NuMeH) group and TecnATox have identified a group of molecules with the potential to improve the Alzheimer's diagnosis process. Published by the journal Cell & Bioscience, the results of this research represent an important step towards having tools that allow diagnosing this neurodegenerative disease when the symptoms are still mild.


The research team has analyzed blood samples from 192 people with mild cognitive impairment, that is, individuals with cognitive and memory problems at risk of developing Alzheimer's, users of the ACE Alzheimer Center Barcelona. The results have identified 15 small non-coding RNA molecules, present in 85% of the participants with a higher risk of developing the disease and would allow the most vulnerable patients to be diagnosed years in advance. These molecules are short chains of nucleotides that, although they contain genetic information, do not have the ability to code for a protein. Instead, they activate or deactivate other RNA molecules that do have the ability to do so.


“Small non-coding RNA molecules, together with traditional methods, have the potential to improve the prediction of Alzheimer's and its early diagnosis,” explains Laia Gutérrez-Tordera, pre-doctoral researcher and lead author of the research. Currently, Alzheimer's disease is diagnosed by clinical symptoms, which can be complemented by neurological imaging tests - such as MRI - and analysis of cerebrospinal fluid through a lumbar puncture, an invasive and uncomfortable procedure. Implementing RNA analysis into diagnostic techniques would improve the patient experience by reducing the use of invasive procedures. Better understanding the function of these molecules in the stages prior to the disease can also help design new preventive and therapeutic strategies that slow the progression of the disease and improve the quality of life of patients.


This study is part of a project funded by the Carlos III Health Institute and led by Dr. Mònica Bulló, Professor of the URV Department of Biochemistry and Biotechnology and current director of TecnATox.

Read more

The journal Sostenible have just published a report on the threat of microplastics for the environment, as seas and oceans are increasingly polluted by these polymers. Joaquim Rovira was interviewed, together with other Catalan researchers, to give a broader  view of the problem and indicate some potential solutions to mitigate medium- and long-term effects of microplastics pollution.

Read more
Dr. Margarita Torrente, leader of the Area of Neuropsychology and Emotions of TecnATox, has been invited by Eurecat and Acelera Pymeas a speaker of the round table entitled Debat sobre innovació en estudis sobre microbiota i salut humana, which will be focused on new advances on microbiota and human health, one of the research areas of the technological center.


It has been organized as a hybrid (on-site and streaming) event scheduled for Wednesday, February 14 (9:30h - 11 h). More information about the round table and the registration link can be found at:


Read more

In January 30, TecnATox organized, in collaboration with REDESSA and the Foodtech & Nutrition Hub, a new TecnATox Annual Workshop. This was special event to welcome TecnATox investigators from SUSCAPE, MINOS, ITAKA and Nutrigenomics research groups.

The Annual Workshop was the core activity of the 1st Forum on Nutrition and Technology of Healthy and Sustainable Food, with the special objetive to create an ideal environment for the collaboration between FoodTech and Nutrition companies and TecnATox researchers.

Read more
Emeritus Professor José L. Domingo is the author of a recent commentary published at the journal Qeios, entitled To Publish Scientific Journals: For Some, the Big Business of the Century. In this publication, Prof. Domingo highlights the proliferation of predatory journals and the adoption of similar profit-driven models by established publishers. The commentary underscores the resulting strain on the peer-review process, with a decline in the availability and quality of reviewers, while he advocates for compensating reviewers if authors are charged for publication. The full commentary can be read at https://www.qeios.com/read/YTFEF2
Read more